CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
OSL:CONTX - Euronext Oslo - SE0014731154 - Common Stock - Currency: NOK
We assign a fundamental rating of 7 out of 10 to CONTX. CONTX was compared to 10 industry peers in the Health Care Technology industry. Both the health and profitability get an excellent rating, making CONTX a very profitable company, without any liquidiy or solvency issues. CONTX may be a bit undervalued, certainly considering the very reasonable score on growth This makes CONTX very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year CONTX was profitable.
CONTX had a positive operating cash flow in the past year.
CONTX had positive earnings in 4 of the past 5 years.
In the past 5 years CONTX always reported a positive cash flow from operatings.
1.2 Ratios
CONTX has a better Return On Assets (10.31%) than 90.00% of its industry peers.
The Return On Equity of CONTX (14.29%) is better than 80.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 12.59%, CONTX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CONTX is significantly above the industry average of 7.82%.
The last Return On Invested Capital (12.59%) for CONTX is well below the 3 year average (36.72%), which needs to be investigated, but indicates that CONTX had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 14.29% | ||
| ROIC | 12.59% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
The Profit Margin of CONTX (10.66%) is better than 70.00% of its industry peers.
CONTX's Profit Margin has improved in the last couple of years.
The Operating Margin of CONTX (12.82%) is better than 80.00% of its industry peers.
CONTX's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 97.41%, CONTX belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
CONTX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.82% | ||
| PM (TTM) | 10.66% | ||
| GM | 97.41% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CONTX is creating value.
CONTX has about the same amout of shares outstanding than it did 1 year ago.
CONTX has about the same amout of shares outstanding than it did 5 years ago.
CONTX has a worse debt/assets ratio than last year.
2.2 Solvency
CONTX has a debt to FCF ratio of 0.50. This is a very positive value and a sign of high solvency as it would only need 0.50 years to pay back of all of its debts.
The Debt to FCF ratio of CONTX (0.50) is better than 80.00% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that CONTX is not too dependend on debt financing.
CONTX has a better Debt to Equity ratio (0.08) than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.5 | ||
| Altman-Z | N/A |
ROIC/WACC1.82
WACC6.93%
2.3 Liquidity
CONTX has a Current Ratio of 3.66. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CONTX (3.66) is better than 100.00% of its industry peers.
CONTX has a Quick Ratio of 3.59. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CONTX (3.59) is better than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.66 | ||
| Quick Ratio | 3.59 |
3. Growth
3.1 Past
CONTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -60.55%.
Measured over the past years, CONTX shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.26% on average per year.
Looking at the last year, CONTX shows a decrease in Revenue. The Revenue has decreased by -9.00% in the last year.
CONTX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.51% yearly.
EPS 1Y (TTM)-60.55%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-136.36%
Revenue 1Y (TTM)-9%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-24.22%
3.2 Future
Based on estimates for the next years, CONTX will show a very strong growth in Earnings Per Share. The EPS will grow by 21.49% on average per year.
The Revenue is expected to grow by 5.99% on average over the next years.
EPS Next Y41.38%
EPS Next 2Y24.57%
EPS Next 3Y21.49%
EPS Next 5YN/A
Revenue Next Year-3.12%
Revenue Next 2Y0.39%
Revenue Next 3Y3.28%
Revenue Next 5Y5.99%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 25.94, the valuation of CONTX can be described as expensive.
70.00% of the companies in the same industry are more expensive than CONTX, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.45. CONTX is around the same levels.
Based on the Price/Forward Earnings ratio of 9.55, the valuation of CONTX can be described as reasonable.
CONTX's Price/Forward Earnings ratio is rather cheap when compared to the industry. CONTX is cheaper than 90.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.90. CONTX is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.94 | ||
| Fwd PE | 9.55 |
4.2 Price Multiples
CONTX's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CONTX indicates a somewhat cheap valuation: CONTX is cheaper than 70.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.82 | ||
| EV/EBITDA | 11.71 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of CONTX may justify a higher PE ratio.
A more expensive valuation may be justified as CONTX's earnings are expected to grow with 21.49% in the coming years.
PEG (NY)0.63
PEG (5Y)0.95
EPS Next 2Y24.57%
EPS Next 3Y21.49%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.18%, CONTX is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.96, CONTX pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.42, CONTX pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y24.57%
EPS Next 3Y21.49%
OSL:CONTX (7/4/2025, 7:00:00 PM)
4.67
-0.03 (-0.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners10.82%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap361.32M
Analysts40
Price Target5.61 (20.13%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-21.43%
PT rev (3m)-21.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.94 | ||
| Fwd PE | 9.55 | ||
| P/S | 2.8 | ||
| P/FCF | 17.82 | ||
| P/OCF | 13.11 | ||
| P/B | 3.76 | ||
| P/tB | 3.89 | ||
| EV/EBITDA | 11.71 |
EPS(TTM)0.18
EY3.85%
EPS(NY)0.49
Fwd EY10.48%
FCF(TTM)0.26
FCFY5.61%
OCF(TTM)0.36
OCFY7.63%
SpS1.67
BVpS1.24
TBVpS1.2
PEG (NY)0.63
PEG (5Y)0.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 14.29% | ||
| ROCE | 15.94% | ||
| ROIC | 12.59% | ||
| ROICexc | 44.69% | ||
| ROICexgc | 50.4% | ||
| OM | 12.82% | ||
| PM (TTM) | 10.66% | ||
| GM | 97.41% | ||
| FCFM | 15.71% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexcg growth 3Y-39.35%
ROICexcg growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score4
Asset Turnover0.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.5 | ||
| Debt/EBITDA | 0.29 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 107.84% | ||
| Profit Quality | 147.45% | ||
| Current Ratio | 3.66 | ||
| Quick Ratio | 3.59 | ||
| Altman-Z | N/A |
F-Score4
WACC6.93%
ROIC/WACC1.82
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60.55%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-136.36%
EPS Next Y41.38%
EPS Next 2Y24.57%
EPS Next 3Y21.49%
EPS Next 5YN/A
Revenue 1Y (TTM)-9%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-24.22%
Revenue Next Year-3.12%
Revenue Next 2Y0.39%
Revenue Next 3Y3.28%
Revenue Next 5Y5.99%
EBIT growth 1Y-60.97%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-3.57%
EBIT Next 3Y20.51%
EBIT Next 5YN/A
FCF growth 1Y-35.26%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-34.27%
OCF growth 3Y51.49%
OCF growth 5Y5.6%